- This event has passed.
Meet with… The Bill & Melinda Gates Foundation
May 24, 2016 @ 10:30 am - 12:30 pm
What does it take to save a life? The Bill & Melinda Gates Foundation Global Health Division aims to harness advances in science and technology to save lives in developing countries. The Foundation works with partners to deliver proven tools – including vaccines, drugs, and diagnostics – as well as discover path-breaking new solutions that are affordable and reliable. Focus areas for investments center on infectious diseases including HIV, polio, TB, dengue and malaria, as well as diagnostics and health IT ideas that bring health interventions to those who need them most.
James Rosen, Gates Foundation Venture Capital Deputy Director for Program Related Investments, will be in attendance to provide an overview presentation on the Foundation’s key areas of interest and best practices when applying for funding. The Gates Foundation has made $3.6 billion in grant payments in 2013 with a total of $31.6 billion in grant payments since its inception.
Jimmy will be on hand to meet with a handful of applicants one-on-one. To be considered for a one-on-one meeting complete the information required here.
10:30am | Registration and Networking
11:00am | Presentation and Q&A
11:45am | Networking Lunch
12:30-5:00pm | One-on-one Meetings*
*Companies must have applied for a one-on-one meeting ahead of time and be approved. The application period ends on April 25th.
Bill & Melinda Gates Foundation Participating Representative:
James Rosen | Venture Capital Deputy Director, Program Related Investments, Bill & Melinda Gates Foundation
Jimmy joined the Bill & Melinda Gates Foundation in February 2015 after spending the prior 10-years with Intersouth Partners. His team is responsible for venture capital investing to support programs of strategic importance to the foundation, with a special focus on biotechnology as it pertains to the foundation’s Global Health efforts. Before joining Intersouth, Jimmy spent 15 years in clinical, research and financial positions in global health, health care and biotechnology. Jimmy’s experience includes research at the Duke Comprehensive Cancer Center, the UNC Lineberger Comprehensive Cancer Center, the Department of Community & Family Medicine at Duke University Medical Center and as a contractor for the National Cancer Institute. He also spent several years as an equity research analyst with Brean Murray & Co., covering biopharmaceuticals, genomics, generics, drug delivery and medical device companies. Prior to research, Jimmy spent five years in Emergency Medical Services as a mountain search & rescue and ambulance medic.
Connect with Jimmy:
Presentation & Lunch
CA$ 35 | General Public
CA$ 50 | General Public Onsite
Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Pre-registration to attend the presentation, Q&A, and lunch will remain open until noon on May 23rd (or sold out).
FREE | Application
FREE | Accepted Companies
Companies must have applied for a one-on-one meeting ahead of time. The one-on-one application period ends on April 25th. Your application will be reviewed and you will be notified of acceptance on May 10th. Acceptance of one-on-one meetings is not guaranteed as all applications must be approved.
About the Meet with… Series:
The purpose of the Meet with Series events sponsored by JLABS is to help start-up entrepreneurs, as well as the academic community, connect with potential partners, such as big pharma or other investment corporations, through one-on-one meetings. It is also a chance for the featured corporation to outline their specific business development goals and clarify what types of products or research they are interested in and how best to approach them to get the partnering process started. Past participants include the Wellcome Trust, Bill & Melinda Gates Foundation, MedImmune Ventures, NCI, Mercury Fund, DARPA’s Biological Technologies Office, Correlation Ventures, Breakout Labs, New Enterprise Associates, Canaan Partners, Thomas McNerney & Partners, NCATS, NINDS, Johnson & Johnson Innovation, Poliwogg, California Institute for Regenerative Medicine, Astellas Venture Management, and OrbiMed.
To be confirmed